Caribou Biosciences
CRBU
CRBU
133 hedge funds and large institutions have $273M invested in Caribou Biosciences in 2022 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 35 increasing their positions, 39 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
10% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 39
40% less capital invested
Capital invested by funds: $457M → $273M (-$184M)
Holders
133
Holding in Top 10
3
Calls
$588K
Puts
$61K
Top Buyers
| 1 | +$10.5M | |
| 2 | +$5.29M | |
| 3 | +$5.05M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.82M |
| 5 |
BlackRock
New York
|
+$1.53M |
Top Sellers
| 1 | -$9.67M | |
| 2 | -$9.46M | |
| 3 | -$4.63M | |
| 4 |
DFO
Duquesne Family Office
New York
|
-$2.86M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$1.84M |